Piwi-interacting RNAs (piRNAs) are essential to repress transposable elements in the animal germline. In the nematode worm C. elegans, piRNA…
The protein kinase Akt is activated in the PI3K pathway by a combination of signaling phospholipids and phosphorylation by upstream protein kinases.…
Valneva announced the initiation of a further Phase 3 trial (VLA2001-304) for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.…
The PhD student and dedicated science communicator Adrià Nogales Moral (Köhler lab) has written a children´s book about tardigrades, runs his own…
Valneva announced positive topline results from the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate, VLA1553. VLA1553 was…
AFFiRiS AG announced that AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, is…
SARSeq, the highly efficient method developed to detect SARS-CoV-2 by scientists around Ulrich Elling (IMBA) and Luisa Cochella (IMP), has been…
The Israeli ambassador in Austria Mordechai Rodgold and the Deputy Chief of Mission Maya Karmely-Sommer visited the Vienna BioCenter earlier today.
For the past two months, the lab of Andrea Pauli at the IMP has been working with an exceptional intern. In June, Eduardo Isaac Martinez Barrios, a…
Cells integrate internal and external stimuli through complex signaling pathways in order to adapt to changing environments. In particular, cells must…
Scientists at the IMP and collaborators have investigated how different forms of cancer therapy can influence the efficacy of subsequent therapies.…
Valneva announced that it has been awarded Breakthrough Therapy Designation for its single-shot chikungunya vaccine candidate, VLA1553, by the U.S.…
The website uses cookies to ensure you get the best experience on our website.
Anonymous evaluation for troubleshooting and further development
Purpose: error analysis, statistical evaluation of our website accesses, campaign analysis, conversion tracking, retargeting Processing operations: Collection of access data, data from your browser and data about the content accessed; Execution of analysis software and storage of data on your terminal device, anonymization of the data collected; Evaluation of the anonymous data in the form of statistics Storage period: data on your device for up to two years. Joint controller: Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland Legal basis for data processing: voluntary, consent that can be revoked at any time Consequences of non-consent: No direct impact on the functionality of the website; however limited opportunities for further development and error analysis Data transfer to the USA: Your data is processed by the provider Google in the USA, which involves corresponding risks, e.g. B. a secret data access by US authorities. With your consent, you also consent to the processing of your data in the USA.
